Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells. | Viruses | 2023 | 37243268 | PubTator, text mining | PubMed |
| The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases. | Biomolecules | 2023 | 37238743 | PubTator, text mining | PubMed |
| AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK. | PLoS Comput Biol | 2023 | 37235579 | PubTator, text mining | PubMed |
| Characterization of BoHV-4 ORF45. | Front Microbiol | 2023 | 37234529 | PubTator, text mining | PubMed |
| The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer. | Mol Cancer | 2023 | 37210549 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| Environment- and epigenome-wide association study of obesity in 'Children of 1997' birth cohort. | Elife | 2023 | 37204309 | PubTator, text mining | PubMed |
| Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma. | Cancers (Basel) | 2023 | 37190302 | PubTator, text mining | PubMed |
| Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 | 37188939 | PubTator, text mining | PubMed |
| Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1. | ACS Omega | 2023 | 37179615 | PubTator, text mining | PubMed |
| Analysis of Vibration, Deflection Angle and Surface Roughness in Water-Jet Cutting of AZ91D Magnesium Alloy and Simulation of Selected Surface Roughness Parameters Using ANN. | Materials (Basel) | 2023 | 37176264 | PubTator, text mining | PubMed |
| FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer. | Int J Mol Sci | 2023 | 37176013 | PubTator, text mining | PubMed |
| Cell Therapy as Target Therapy against Colon Cancer Stem Cells. | Int J Mol Sci | 2023 | 37175871 | PubTator, text mining | PubMed |
| Senolytic Flavonoids Enhance Type-I and Type-II Cell Death in Human Radioresistant Colon Cancer Cells through AMPK/MAPK Pathway. | Cancers (Basel) | 2023 | 37174126 | PubTator, text mining | PubMed |
| Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis. | Tumour Virus Res | 2023 | 37169175 | PubTator, text mining | PubMed |
| Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis. | Front Med (Lausanne) | 2023 | 37153094 | PubTator, text mining | PubMed |
| miR‑4732‑5p promotes ovarian cancer mobility by targeting MCUR1. | Oncol Lett | 2023 | 37153048 | PubTator, text mining | PubMed |
| TRA2: The dominant power of alternative splicing in tumors. | Heliyon | 2023 | 37151663 | PubTator, text mining | PubMed |
| The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. | J Biol Chem | 2023 | 37149146 | PubTator, text mining | PubMed |
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=12